Concord Drugs Ltd | Scrip Code : 538965 | Quarter ending :December 2019 |
| Declaration
| |
|
|
Whether the Listed Entity has issued any partly paid up shares? | No | Whether the Listed Entity has issued any Convertible Securities ? | No | Whether the Listed Entity has issued any Warrants ? | No | Whether the Listed Entity has any shares against which depository receipts are issued? | No | Whether the Listed Entity has any shares in locked-in? | Yes | Whether any shares held by promoters are pledge or otherwise encumbered? | No | Whether company has equity shares with differential voting rights? | No |
| Summary statement holding of specified securities
| |
|
|
(A) Promoter & Promoter Group | 4 | 37,40,500 | 37,40,500 | 42.78 | 37,40,500 | 42.78 | 29,38,600 | 78.56 | 30,58,500 | - | - | - | (B) Public | 1,975 | 50,03,250 | 50,03,250 | 57.22 | 50,03,250 | 57.22 | 2,00,000 | 4.00 | 40,45,350 | - | - | - | (C1) Shares underlying DRs | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C2) Shares held by Employee Trust | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C) Non Promoter-Non Public | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | Grand Total | 1,979 | 87,43,750 | 87,43,750 | 100.00 | 87,43,750 | 100.00 | 31,38,600 | 35.90 | 71,03,850 | - | - | - |
| Note:C=C1+C2 Grand Total=A+B+C
|